Review of laser-assisted cataract surgery published (Dec 2019)

This month, a review paper has been published in the European Journal of Ophthalmology authored by specialists at multiple central London teaching hospitals. This paper has systematically looked at the published evidence base to date for laser-assisted cataract surgery. Upon reviewing 121 suitable publications, the authors have concluded that “the current clinical outcomes of femtosecond… Read More

Femtosecond laser-assisted cataract surgery

Earlier this year, a randomised controlled clinical trial was published from the group at St Thomas’ Hospital in London, directly comparing outcomes of conventional cataract surgery with laser-assisted cataract surgery. With 200 eyes in each trial group, the study found virtually no meaningful differences in outcome for the two groups in terms of level of… Read More

Anti-VEGF injections for proliferative diabetic retinopathy

Retinal specialists knew that this would be on the cards at some point, but managing proliferative diabetic retinopathy (PDR) with regular intravitreal injections is not standard practice in the UK. This is perhaps due to cost, service pressures, or the fear of non-attendance or service-initiated re-schedulings causing re-proliferation at the retina and subsequent complications such… Read More

Outcomes of laser-assisted vs manual cataract surgery

Laser-assisted cataract surgery has emerged as an alternative to traditional (manual) cataract surgery in recent years, but several studies have failed to provide evidence of major advantages of the technology, while others have demonstrated that laser-assisted cataract surgery may actually increase complication rates. This recent, large, single-centre study examined visual and refractive outcomes on around… Read More

New anti-VEGF agent for macular degeneration shows promise

Phase 2 studies of brolucizumab show similar efficacy to aflibercept (Eylea) for wet age-related macular degeneration (AMD) and the drug is now advancing to Phase 3 trials. Wet AMD is becoming more prevalent and the higher the number of treatment options, the better. What is interesting is that the brolucizumab group in the study may… Read More

The risks of not using iodine during intravitreal injections

Intravitreal injections are frequently administered to patients with wet macular degeneration, retinal vein occlusion or diabetic eye disease. During the injection procedure, povidone-iodine drops are used to disinfect the ocular surface, which reduces the risk of post-injection infection in the eye (endophthalmitis – which is very rare but can cause significant visual loss if it… Read More

Scharioth Macula Lens – magnifier in the eye

The Scharioth Macula Lens (SML) is a magnifying add-on lens implant, designed for eyes which have already had cataract surgery and which also have macular disease such as macular degeneration. It aims to improve reading vision and near visual function significantly, by enabling reading of small print at short distances of around 15cm. The inventor… Read More